Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease

Neurology ◽  
2006 ◽  
Vol 66 (Issue 10, Supplement 4) ◽  
pp. S89-S103 ◽  
Author(s):  
B. Dass ◽  
C. W. Olanow ◽  
J. H. Kordower
2013 ◽  
Vol 22 (7) ◽  
pp. 1263-1279 ◽  
Author(s):  
Jisook Moon ◽  
Hyun-Seob Lee ◽  
Jun Mo Kang ◽  
Junpil Park ◽  
Amanda Leung ◽  
...  

2005 ◽  
Vol 32 (06) ◽  
Author(s):  
GU Höglinger ◽  
P Rizk ◽  
WH Oertel ◽  
EC Hisch

2021 ◽  
Vol 22 (3) ◽  
pp. 1154
Author(s):  
Yong-Ren Chen ◽  
Pei-Lun Lai ◽  
Yueh Chien ◽  
Po-Hui Lee ◽  
Ying-Hsiu Lai ◽  
...  

The authors regret to have made a mistake in publishing this paper [...]


2021 ◽  
pp. 1-6
Author(s):  
Asuka Morizane ◽  
Jun Takahashi

Stem cell-based therapies for Parkinson’s disease are now being applied clinically. Notably, studies have shown that controlling the graft-induced immune response improves the results. In this mini-review, we concisely summarize current approaches used for this control. We focus on four modes of stem cell-based therapies: autologous transplantation, allogeneic transplantation with human leukocyte antigen-matching and allogeneic transplantation without, and finally the application of “universal” pluripotent stem cells. We also discuss immuno-suppressive treatments and the monitoring of immune reactions in the brain.


Sign in / Sign up

Export Citation Format

Share Document